Silverback Therapeutics Inc. (SBTX) NASDAQ

$3.26 0.01 (0.31%)

Market Cap: $114.57M

As of 05/25/22 04:00 PM EDT. Market closed.

(SBTX)

Silverback Therapeutics Inc. (SBTX) NASDAQ

$3.26 0.01 (0.31%)

Market Cap: $114.57M

As of 05/25/22 04:00 PM EDT. Market closed.

Silverback Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops novel and proprietary ImmunoTAC technology, which is designed to create potent therapeutic molecules that can be systemically administered to patients. Silverback Therapeutics serves customers ... read more

Silverback Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops novel and proprietary ImmunoTAC technology, which is designed to create potent therapeutic molecules that can be systemically administered to patients. Silverback Therapeutics serves customers worldwide. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
54
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$3.27
Previous Close
$3.25
Days Range
$3.20 - $3.32
52 week range
$2.80 - $35.63
Volume
229,152
Avg. Volume (30 days)
356,211
Market Cap
$114.57M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
35,145,281
Open
$3.27
Previous Close
$3.25
Days Range
$3.20 - $3.32
52 week range
$2.80 - $35.63
Volume
229,152
Avg. Volume (30 days)
356,211
Market Cap
$114.57M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
35,145,281

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SILVERBACK THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
ROOT JONATHAN D Director Nov 15, 2021 Buy $8.85 2,014 17,824 2,364 Mar 18, 2022, 05:14 PM
ROOT JONATHAN D Director Mar 03, 2021 Buy $52.07 350 18,224 350 Mar 18, 2022, 05:14 PM
Hawkinson Russ Sr. Vice President of Finance Dec 08, 2020 Buy $21.00 200 4,200 200 Feb 24, 2022, 07:55 PM
Presidio Management Group XII, L.L.C. 10% Owner Dec 08, 2020 Buy $21.00 47,619 999,999 47,619 Dec 08, 2020, 09:04 PM
CAPPS VICKIE L Director Dec 08, 2020 Buy $21.00 9,523 199,983 61,576 Dec 08, 2020, 08:56 PM
Hawkinson Russ Sr. Vice President of Finance Dec 08, 2020 Buy $21.00 238 4,998 238 Dec 08, 2020, 08:52 PM
Piazza Jonathan Chief Financial Officer Dec 08, 2020 Buy $21.00 11,904 249,984 11,904 Dec 08, 2020, 08:50 PM
Schroeder Thilo Director Dec 08, 2020 Buy $21.00 238,096 5,000,016 238,096 Dec 08, 2020, 08:48 PM
ROOT JONATHAN D Director Dec 08, 2020 Buy $21.00 95,238 1,999,998 95,238 Dec 08, 2020, 08:46 PM
Thompson Peter A. Director Dec 08, 2020 Buy $21.00 952,377 19,999,917 952,377 Dec 08, 2020, 08:43 PM
Thompson Peter A. Director Dec 08, 2020 Buy $21.00 238,100 5,000,100 507,423 Dec 08, 2020, 08:43 PM
ORBIMED ADVISORS LLC Director Dec 08, 2020 Buy $21.00 238,100 5,000,100 507,423 Dec 08, 2020, 08:41 PM
ORBIMED ADVISORS LLC Director Dec 08, 2020 Buy $21.00 952,377 19,999,917 952,377 Dec 08, 2020, 08:41 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
ROOT JONATHAN D Director 11/15/2021 17,824
ROOT JONATHAN D Director 03/03/2021 18,224
Hawkinson Russ Sr. Vice President of Finance 12/08/2020 4,200
Presidio Management Group XII, L.L.C. 10% Owner 12/08/2020 999,999
CAPPS VICKIE L Director 12/08/2020 199,983
Hawkinson Russ Sr. Vice President of Finance 12/08/2020 4,998
Piazza Jonathan Chief Financial Officer 12/08/2020 249,984
Schroeder Thilo Director 12/08/2020 5,000,016
ROOT JONATHAN D Director 12/08/2020 1,999,998
Thompson Peter A. Director 12/08/2020 19,999,917
Thompson Peter A. Director 12/08/2020 5,000,100
ORBIMED ADVISORS LLC Director 12/08/2020 5,000,100
ORBIMED ADVISORS LLC Director 12/08/2020 19,999,917
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2021
03/31/2021
0.15%
1Q

Period of Report: 06/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2021
0.15%
1Q